Tenon Medical, Inc.
TNON
$1.17
$0.021.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.25% | 32.59% | 31.32% | 33.03% | 17.63% |
| Total Depreciation and Amortization | 53.76% | 76.55% | 72.26% | 64.29% | 47.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.25% | -9.42% | -4.20% | -24.55% | -15.08% |
| Change in Net Operating Assets | 36.40% | -111.85% | -152.22% | -150.87% | -168.12% |
| Cash from Operations | 18.92% | 29.43% | 24.80% | 16.69% | -1.31% |
| Capital Expenditure | 48.48% | 63.79% | 69.89% | 50.68% | 57.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -93.61% | 203.67% | 419.24% |
| Cash from Investing | -103.03% | -103.67% | -96.70% | 154.36% | 312.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.39% | 34.58% | -44.11% | -46.99% | -60.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 797.84% | 1,262.54% | -117.86% | -3,492.31% | -1,936.00% |
| Cash from Financing | 124.14% | 213.55% | 29.48% | -24.15% | -55.35% |
| Foreign Exchange rate Adjustments | 21.05% | 251.72% | 7.46% | 2,025.00% | 442.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,273.58% | 2,556.42% | -91.99% | 180.71% | 137.94% |